This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Series A leads to €5mm for two-year-old Complix NV; €2mm added
Complix NV (developing a new class of therapeutics for autoimmune and infectious diseases) has raised €5mm ($6.1mm) in its Series A financing co-led by Vesalius Biocapital and LRM. Also participating in the round were returning shareholders, company management, and public research institute CRP-Santé, which is collaborating with Complix on antiviral therapies.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?